JCOPO_ASCO Profile Banner
JCO Precision Oncology Profile
JCO Precision Oncology

@JCOPO_ASCO

Followers
5K
Following
1K
Media
478
Statuses
1K

Original research, reports, opinions, and reviews advancing the science and practice of #precisiononcology. Part of @JCO_ASCO family of journals.

Joined July 2016
Don't wanna be here? Send us removal request.
@JCOPO_ASCO
JCO Precision Oncology
22 hours
Enhanced Detection of Druggable Mutations in Non–Small.Cell Lung Cancer Using Targeted Collection of Bronchial.Washing Fluid Compared With Plasma and Tumor Tissue. Read the full article: #NSCLC #LungCancer.
Tweet card summary image
ascopubs.org
PURPOSENext-generation sequencing (NGS) has become the gold standard for the molecular testing of patients with non–small cell lung cancer (NSCLC). This prospective study evaluated the performance of...
0
0
3
@JCOPO_ASCO
JCO Precision Oncology
2 days
RT @EdEsplin: HIgher rwOS in #Patients w/ #EGFR mutated #NSCLC & #germline #BRCA or #PALB2 PGVs vs #patients w/o #BRCA/#PALB2. Possibly 2/2….
0
4
0
@JCOPO_ASCO
JCO Precision Oncology
2 days
RT @tuttsakhil: Multi-Regional Profiling of Epidermal Growth Factor Receptor L858R Mutation-Positive Metastatic Renal Pelvic Cancer Success….
Tweet card summary image
ascopubs.org
0
2
0
@JCOPO_ASCO
JCO Precision Oncology
2 days
Prognostic Indicators of Preoperative Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel Efficacy in Locally Advanced Gastroesophageal and Gastric Cancer: Integrating Biomarker Analysis and Clinicopathological Factors. Read the full article.
Tweet card summary image
ascopubs.org
PURPOSEPerioperative fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) is a standard treatment for locally advanced gastric/gastroesophageal junction cancer (GC/GEJC). The impact of...
1
0
2
@JCOPO_ASCO
JCO Precision Oncology
3 days
Mucin 16–Directed Therapy in #PediatricSarcomas: Case.Evidence of Ubamatamab Efficacy in Epithelioid Sarcoma and Its Implications for Other Sarcoma Subtypes. Read the full article: .#pedonc.
Tweet card summary image
ascopubs.org
PURPOSEEpithelioid sarcoma (ES) and malignant rhabdoid tumor (MRT) are rare soft tissue sarcomas with poor prognoses. Although mucin 16 (MUC16) and its soluble form, cancer antigen 125 (CA125), are...
0
0
2
@JCOPO_ASCO
JCO Precision Oncology
4 days
RT @tuttsakhil: Mucin 16–Directed Therapy in Pediatric Sarcomas: Case Evidence of Ubamatamab Efficacy in Epithelioid Sarcoma and Its Implic….
Tweet card summary image
ascopubs.org
PURPOSEEpithelioid sarcoma (ES) and malignant rhabdoid tumor (MRT) are rare soft tissue sarcomas with poor prognoses. Although mucin 16 (MUC16) and its soluble form, cancer antigen 125 (CA125), are...
0
1
0
@JCOPO_ASCO
JCO Precision Oncology
4 days
RT @KoheiShitara: Please to share biomarker analysis of FLOT-treated gastric/GEJ cancer @JCOPO_ASCO @ASCO : CLDN18.2 expression declined af….
0
18
0
@JCOPO_ASCO
JCO Precision Oncology
8 days
Genomic Landscape and Clinical Relevance in Chinese.Patients With Upper Tract Urothelial Carcinoma. Read the full article.
Tweet card summary image
ascopubs.org
PURPOSEUpper tract urothelial carcinoma (UTUC) is one of the common urothelial cancers. Although large cohorts have illustrated spectrum of germline mutations, landscape of somatic alterations has...
0
0
3
@JCOPO_ASCO
JCO Precision Oncology
9 days
Physiologically Based Pharmacokinetic Model to Assess the Drug-Drug-Gene Interaction Potential of Belzutifan in.Combination With Cyclin-Dependent Kinase 4/6 Inhibitors. Read the full article.
Tweet card summary image
ascopubs.org
PURPOSEBelzutifan is a novel treatment for von Hippel-Lindau–associated cancers and is being evaluated in clinical trials for the treatment of renal cell carcinoma in combination with the cyclin-de...
0
0
2
@JCOPO_ASCO
JCO Precision Oncology
10 days
CNS Involvement by North American North American-Adult T-cell Leukemia/Lymphoma Is Associated With Discrete Dissemination Patterns and Molecular Profiles, Involving XPO1 E571 and KLF2/PI3KCD in Selected Cases. Read the full article.
Tweet card summary image
ascopubs.org
PURPOSECNS involvement in North American adult T-cell leukemia/lymphoma (NA-ATLL) remains poorly understood. This study examined the CNS involvement in patients with ATLL treated at a tertiary...
0
0
1
@JCOPO_ASCO
JCO Precision Oncology
10 days
Prospective Clinical Validation of a Combinatorial Functional Precision Medicine Platform in Relapsed/Refractory Non-Hodgkin's Lymphoma. Read full article.
Tweet card summary image
ascopubs.org
PURPOSEDespite initially responding to first-line treatment, many patients with non-Hodgkin's lymphoma (NHL) eventually relapse or are refractory. These patients are empirically subjected to salvage...
0
0
2
@JCOPO_ASCO
JCO Precision Oncology
11 days
Deep-Learning Model for Real-Time Prediction of Recurrence in Early-Stage Non–Small Cell Lung Cancer: A Multimodal Approach (RADAR CARE Study). Co-authored by @HyunAeJung62662. Read full article.
Tweet card summary image
ascopubs.org
PURPOSEThe surveillance protocol for early-stage non–small cell lung cancer (NSCLC) is not contingent upon individualized risk factors for recurrence. This study aimed to use comprehensive data from...
1
0
2
@JCOPO_ASCO
JCO Precision Oncology
12 days
RT @tuttsakhil: Case of KRAS G12C-Mutated AML Treated With Sotorasib | @JCOPO_ASCO
Tweet card summary image
ascopubs.org
0
1
0
@JCOPO_ASCO
JCO Precision Oncology
16 days
.@HyunAeJung62662 et al's pilot study introduces a deep-learning model that uses multimodal data from routine clinical practice to predict relapses in early-stage #NSCLC. Read the full article. .#LCSM
Tweet media one
0
2
5
@JCOPO_ASCO
JCO Precision Oncology
16 days
RT @tuttsakhil: Combination Therapy With Olaparib Plus Lenvatinib in a Patient With BRCA2-Mutated, Radioiodine-Refractory, Metastatic Papil….
Tweet card summary image
ascopubs.org
0
1
0
@JCOPO_ASCO
JCO Precision Oncology
18 days
RT @tuttsakhil: Response-Adapted Surgical and Radiotherapy De-Escalation in Resectable Cutaneous Squamous Cell Cancer Using Pembrolizumab:….
Tweet card summary image
ascopubs.org
PURPOSEThe high rates of pathologic complete response (pCR) after neoadjuvant immunotherapy have generated interest for a risk adaptive surgical and radiotherapy-free management approach to reduce...
0
1
0
@JCOPO_ASCO
JCO Precision Oncology
18 days
Cancer Testis Antigen Expression Correlates With Immune.Activation and Survival in Small Bowel Neuroendocrine Tumors. Read the full article.
Tweet card summary image
ascopubs.org
PURPOSESmall bowel neuroendocrine tumors (SBNET) frequently present with metastatic disease, and the efficacy of available systemic therapies, especially immune checkpoint blockade, is limited....
0
1
3